Express Pharma

Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData

The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to boost drugs production further